Kinloch Capital’s OrthoPediatrics KIDS Stock Holding History

Kinloch Capital’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-583	Closed	-$24K	–	130
2020 Q4	$24K	Buy	+583	New	+$26.7K	0.02%	141

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Kinloch Capital's KIDS Position: Q1 2021 in Review

Kinloch Capital sold out of OrthoPediatrics (KIDS) in Q1 2021, closing a stake of 583 shares — an estimated $24K sold.

Kinloch Capital first reported a position in KIDS in Q4 2020 and held it in 1 quarter. The position peaked at $24K in Q4 2020. 126 funds tracked by Wall St. Rank hold KIDS as of Q1 2021.

Kinloch Capital reported no remaining OrthoPediatrics position as of Q1 2021 after selling out during the quarter.
Kinloch Capital sold 583 OrthoPediatrics shares in Q1 2021, an estimated $24K.
Kinloch Capital first reported a position in OrthoPediatrics in Q4 2020 and held it in 1 quarter.
Kinloch Capital's OrthoPediatrics position peaked at $24K in Q4 2020.
126 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2021.

Based on Kinloch Capital's 13F filing for Q1 2021, filed 11 May 2021.